373 related articles for article (PubMed ID: 30950651)
1. Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population.
Alzahrani T; Nguyen T; Ryan A; Dwairy A; McCaffrey J; Yunus R; Forgione J; Krepp J; Nagy C; Mazhari R; Reiner J
Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e005597. PubMed ID: 30950651
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease in transgender people: a systematic review and meta-analysis.
van Zijverden LM; Wiepjes CM; van Diemen JJK; Thijs A; den Heijer M
Eur J Endocrinol; 2024 Feb; 190(2):S13-S24. PubMed ID: 38302717
[TBL] [Abstract][Full Text] [Related]
3. Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014-2017 BRFSS.
Caceres BA; Jackman KB; Edmondson D; Bockting WO
J Behav Med; 2020 Apr; 43(2):329-338. PubMed ID: 31559524
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Replacement Therapy in Relation With Cardiovascular Disease in Cisgender Women and Transgender People.
Lopez DS; Mulla JS; El Haddad D; Tahashilder MI; Polychronopolou E; Baillargeon J; Kuo YF; Gilani S; Khalife WI
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1515-e1523. PubMed ID: 37392459
[TBL] [Abstract][Full Text] [Related]
5. Transgender individuals' cancer survivorship: Results of a cross-sectional study.
Boehmer U; Gereige J; Winter M; Ozonoff A; Scout N
Cancer; 2020 Jun; 126(12):2829-2836. PubMed ID: 32134515
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
Streed CG; Harfouch O; Marvel F; Blumenthal RS; Martin SS; Mukherjee M
Ann Intern Med; 2017 Aug; 167(4):256-267. PubMed ID: 28738421
[TBL] [Abstract][Full Text] [Related]
8. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
Getahun D; Nash R; Flanders WD; Baird TC; Becerra-Culqui TA; Cromwell L; Hunkeler E; Lash TL; Millman A; Quinn VP; Robinson B; Roblin D; Silverberg MJ; Safer J; Slovis J; Tangpricha V; Goodman M
Ann Intern Med; 2018 Aug; 169(4):205-213. PubMed ID: 29987313
[TBL] [Abstract][Full Text] [Related]
9. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.
Newman AB; Spiekerman CF; Enright P; Lefkowitz D; Manolio T; Reynolds CF; Robbins J
J Am Geriatr Soc; 2000 Feb; 48(2):115-23. PubMed ID: 10682939
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease risk among transgender women living with HIV in the United States.
Gosiker BJ; Lesko CR; Rich AJ; Crane HM; Kitahata MM; Reisner SL; Mayer KH; Fredericksen RJ; Chander G; Mathews WC; Poteat TC
PLoS One; 2020; 15(7):e0236177. PubMed ID: 32687532
[TBL] [Abstract][Full Text] [Related]
11. Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States.
Azagba S; Latham K; Shan L
Int J Drug Policy; 2019 Nov; 73():163-169. PubMed ID: 31353246
[TBL] [Abstract][Full Text] [Related]
12. Prostate Cancer Screening Uptake in Transgender Women.
Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
[TBL] [Abstract][Full Text] [Related]
13. Transgender Identity and Cardiovascular Disease.
Howerton I; Harris JK
Transgend Health; 2022 Oct; 7(5):407-415. PubMed ID: 36644490
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.
Wierckx K; Elaut E; Declercq E; Heylens G; De Cuypere G; Taes Y; Kaufman JM; T'Sjoen G
Eur J Endocrinol; 2013 Oct; 169(4):471-8. PubMed ID: 23904280
[TBL] [Abstract][Full Text] [Related]
15. Health and health care access in the US transgender population health (TransPop) survey.
Feldman JL; Luhur WE; Herman JL; Poteat T; Meyer IH
Andrology; 2021 Nov; 9(6):1707-1718. PubMed ID: 34080788
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Predictors of Cardiovascular Disease and Risk Factors in Transgender Persons in the United States.
Malhotra A; Kort S; Lauther T; Mann N; Skopicki HA; Parikh PB
Crit Pathw Cardiol; 2022 Mar; 21(1):42-46. PubMed ID: 34798650
[TBL] [Abstract][Full Text] [Related]
17. [Hormone treatment of transgender people: Long-term health effects and safety].
de Blok CJM; Wiepjes CM; Nota NM; den Heijer M
Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32757514
[TBL] [Abstract][Full Text] [Related]
18. Gender Identity, Sexual Orientation, and Eating-Related Pathology in a National Sample of College Students.
Diemer EW; Grant JD; Munn-Chernoff MA; Patterson DA; Duncan AE
J Adolesc Health; 2015 Aug; 57(2):144-9. PubMed ID: 25937471
[TBL] [Abstract][Full Text] [Related]
19. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC
Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Disease in a Population-Based Sample of Transgender and Cisgender Adults.
Poteat TC; Divsalar S; Streed CG; Feldman JL; Bockting WO; Meyer IH
Am J Prev Med; 2021 Dec; 61(6):804-811. PubMed ID: 34364725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
